| |
| |
|
| Insider
Information: |
Gorman Kevin Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
517,112 |
|
|
Indirect Shares
|
57,996 |
|
|
| Direct
Value |
$72,068,602 |
|
|
|
Indirect Value
|
$8,149,018 |
|
|
| Total
Shares |
575,108 |
|
|
| Total
Value |
$80,217,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XNCR |
Xencor Inc |
Director |
• • – |
2024-02-13 |
4 |
B |
$19.12 |
$1,013 |
D/D |
53 |
5,060 |
2.31 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-09-22 |
4 |
D |
$55.19 |
$100,059 |
I/I |
(1,813) |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-09-22 |
4 |
A |
$55.19 |
$100,059 |
D/D |
1,813 |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2003-05-22 |
4 |
A |
$48.51 |
$97,020 |
D/D |
2,000 |
29,497 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-03-01 |
4 |
A |
$55.15 |
$110,300 |
D/D |
2,000 |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2022-02-08 |
4 |
AS |
$79.49 |
$180,768 |
D/D |
(2,274) |
462,844 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-08 |
4 |
AS |
$104.30 |
$237,185 |
D/D |
(2,274) |
491,365 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-08 |
4 |
AS |
$134.15 |
$305,052 |
D/D |
(2,274) |
506,962 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
AS |
$114.16 |
$276,504 |
D/D |
(2,422) |
443,249 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-01-31 |
4 |
AS |
$110.08 |
$297,997 |
D/D |
(2,707) |
465,278 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-31 |
4 |
AS |
$140.69 |
$380,845 |
D/D |
(2,707) |
502,188 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-07 |
4 |
AS |
$95.12 |
$262,440 |
D/D |
(2,759) |
417,597 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-07 |
4 |
OE |
$8.66 |
$23,893 |
D/D |
2,759 |
420,356 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-13 |
4 |
AS |
$133.02 |
$376,700 |
D/D |
(2,832) |
514,596 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-04-24 |
4 |
AS |
$99.45 |
$289,016 |
D/D |
(2,906) |
434,971 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
officerTitle |
• – – |
2005-12-08 |
4 |
S |
$62.74 |
$188,745 |
D/D |
(3,000) |
55,250 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-02-06 |
4 |
AS |
$43.18 |
$129,972 |
D/D |
(3,010) |
250,542 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-09 |
4 |
OE |
$32.99 |
$99,993 |
D/D |
3,031 |
420,628 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
AS |
$105.68 |
$321,259 |
D/D |
(3,040) |
468,008 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-06 |
4 |
AS |
$142.18 |
$432,218 |
D/D |
(3,040) |
504,919 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2016-02-03 |
4 |
AS |
$38.04 |
$118,875 |
D/D |
(3,125) |
228,077 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-02-03 |
4 |
AS |
$42.55 |
$132,969 |
D/D |
(3,125) |
247,802 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-02-04 |
4 |
AS |
$88.10 |
$275,321 |
D/D |
(3,125) |
408,082 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-02-07 |
4 |
AS |
$103.35 |
$335,696 |
D/D |
(3,248) |
432,357 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-08-05 |
4 |
AS |
$118.91 |
$403,101 |
D/D |
(3,390) |
438,021 |
0 |
% |
|
82 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
